Molecular pathways: targeting p21-activated kinase 1 signaling in cancer--opportunities, challenges, and limitations

Authors

Jeyanthy Eswaran, George Washington University
Da-Qiang Li, George Washington University
Anil Shah, George Washington University
Rakesh Kumar, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

7-15-2012

Journal

Clinical Cancer Research

Volume

Volume 18, Issue 14

Inclusive Pages

3750-3761

Keywords

Cell Transformation; Neoplastic--metabolism; Neoplasms--drug therapy; Protein Kinase Inhibitors--therapeutic use; p21-Activated Kinases--antagonists & inhibitors; p21-Activated Kinases--genetics; p21-Activated Kinases--metabolism

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Eswaran, J., Li, D.Q., Shah, A., Kumar, R. (2012). Molecular pathways: Targeting p21-activated kinase 1 signaling in cancer - Opportunities, challenges, and limitations. Clinical Cancer Research, 18(14), 3750-3761.

Peer Reviewed

1

Open Access

1